Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Thomas H. Nagel"'
Autor:
Brady S. Laughlin, MD, Sasha Ebrahimi, MD, PhD, Molly M. Voss, BA, Samir H. Patel, MD, Robert L. Foote, MD, Lisa A. McGee, MD, Joaquin Garcia, MD, Daniel J. Ma, MD, Yolanda I. Garces, MD, Michelle A. Neben Wittich, MD, Katharine A. Price, MD, Alessandra Schmitt, MD, Qihui Zhai, MD, Byron C. May, MD, Thomas H. Nagel, MD, Michael L. Hinni, MD, Ashish V. Chintakuntlawar, MBBS, PhD, Todd A. DeWees, PhD, Jean-Claude M. Rwigema, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 4, Pp 101204- (2023)
Purpose: This series reports long-term clinical outcomes of patients with salivary duct carcinoma (SDC), which is associated with a poor prognosis. Methods and Materials: Eighty-nine patients with SDC were treated with curative intent from February 5
Externí odkaz:
https://doaj.org/article/ce5c8d672a394f028680444098efe8ba
Autor:
Justin D. Anderson, Todd A. DeWees, Daniel J. Ma, Thomas H. Nagel, Kathryn M. Van Abel, Eric J. Moore, Jean Claude M. Rwigema, David M. Routman, Michelle Neben Wittich, Lisa A. McGee, Richard E. Hayden, Robert L. Foote, Michael Golafshar, Mauricio E. Gamez, Scott C. Lester, Aman Anand, Lisa R. Crujido, Michele Y. Halyard, Michael L. Hinni, Samir H. Patel
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 115:192-201
Our objective was to report the prospective results of mucosal sparing radiation therapy in human papillomavirus-related oropharyngeal squamous cell carcinoma.From March 2016 through May 2019, patients were enrolled in this institutional review board
Publikováno v:
HNO. 70:371-379
Publikováno v:
The Laryngoscope. 132:2162-2163
Autor:
Thomas H. Nagel, Brittany E. Howard, David G. Lott, Brent A. Chang, Richard E. Hayden, Michael L. Hinni
Publikováno v:
Annals of Otology, Rhinology & Laryngology. 128:978-982
Introduction:The ability to treat more advanced laryngeal cancers by transoral approaches has expanded significantly in the past several decades. Transoral management of laryngeal cancers that require removal of the laryngeal framework is controversi
Autor:
David L. Lott, Michael L. Hinni, Brittany E. Howard, Thomas H. Nagel, Carrlene B. Donald, Andrew K. Patel, Brent A. Chang, David P. Mullin, Richard E. Hayden
Publikováno v:
Head & Neck.
Autor:
Joseph M. Hoxworth, Lanyu Mi, Brittany E. Howard, Courtney M. Tomblinson, Leland S. Hu, Geoffrey P. Fletcher, Thomas H. Nagel, Michael L. Hinni
Publikováno v:
HeadneckREFERENCES. 43(7)
BACKGROUND Margins in transoral surgery for tonsil cancer can be limited by oropharyngeal wall thickness (OWT), but the normal range is not well established. METHODS In 240 noncancer subjects, OWT was measured bilaterally in the vicinity of the tonsi
Autor:
Ashish V. Chintakuntlawar, Daniel J. Ma, K. Price, David M. Routman, Q. Zhai, B.C. May, A. Schmitt, Thomas H. Nagel, Michael L. Hinni, Robert L. Foote, S. Ebrahimi, M. Neben Wittich, Lisa A. McGee, J.C. Rwigema, Yolanda I. Garces, Samir H. Patel, J.J. Garcia
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:e413-e414
PURPOSE/OBJECTIVE(S) Salivary duct carcinomas (SDC) make up < 2% of salivary duct tumors but are very aggressive with a low 5-year survival rate of 35%. This series reports long term outcomes of patients with SDC treated at a single institution. MATE
Autor:
Brent A. Chang, David G. Lott, Brittany E. Howard, Thomas H. Nagel, Richard E. Hayden, Michael L. Hinni, Carrlene B. Donald, David P. Mullin, Andrew K. Patel
Publikováno v:
HeadneckREFERENCES. 43(1)
BACKGROUND The aim of the study was to describe a novel technique for reinforcement of salvage laryngectomy closure using a bipedicled musculofascial submental flap. METHODS A retrospective cohort study design identified patients who underwent salvag
Autor:
Samir H. Patel, Ashish V. Chintakuntlawar, D.M. Ma, Michelle A. Neben-Wittich, J.C. Rwigema, B. Fruth, J.R. Janus, Scott C. Lester, K. Price, Thomas H. Nagel, D.L. Price, Jan L. Kasperbauer, K. Van Abel, J.J. Garcia, P. Savvides, Robert L. Foote, Michael L. Hinni, David M. Routman, Eric J. Moore, Lisa A. McGee, Nathan R. Foster, Linda X. Yin
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 111:1324
Purpose/Objective(s) We previously reported the results of a phase II clinical trial evaluating 30-36 Gy of adjuvant radiation therapy (RT) for selected patients with HPV+ OPSCC. Herein we report the two-year results of a phase III trial comparing th